Farmacia Hospitalaria y Farmacogenómica

Gonzalez-Del Vecchio, M; Ruiz-Serrano, MJ; Gijon, P; Sanchez-Somolinos, M; de Egea, V; de Viedma, DG; Fresneda, MNS; Bouza, E.

Differences between a probable and proven BCG infection following intravesical instillations: 16 years experience in a tertiary care hospital

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2016; 85(3): 338-343 Nº de citas: 14 [doi:10.1016/j.diagmicrobio.2016.04.006]

Perez, RP; Garcia, BS; Llamazares, CMF; Artigao, FB; Julian, AN; Pena, MJM.

The challenge of administering anti-tuberculosis treatment in infants and pre-school children. pTBred Magistral Project

ANALES DE PEDIATRIA. 2016; 85(1): 4-12 Nº de citas: 11 [doi:10.1016/j.anpedi.2015.07.027]

Cortejoso, L; Garcia-Gonzalez, X; Garcia, MI; Garcia-Alfonso, P; Sanjurjo, M; Lopez-Fernandez, LA.

Cost-effectiveness of screening for DPYD polymorphisms to prevent neutropenia in cancer patients treated with fluoropyrimidines

PHARMACOGENOMICS. 2016; 17(9): 979-984 Nº de citas: 40 [doi:10.2217/pgs-2016-0006]

Romero-Jimenez, RM; Escudero-Vilaplana, V; Baniandres Rodriguez, O; Garcia-Gonzalez, X; Sanjurjo Saez, M.

Efficiency of biological therapies in patients with moderate to severe psoriasis: impact of a pharmacotherapeutic protocol

JOURNAL OF DERMATOLOGICAL TREATMENT. 2016; 27(3): 198-202 Nº de citas: 7 [doi:10.3109/09546634.2015.1088127]

De Lorenzo-Pinto, A; Garcia-Sanchez, R; Duran-Garcia, E; Castuera-Gil, A; Pascual-Izquierdo, C; Marzal-Alfaro, B; Arrabal-Duran, P; Herranz-Alonso, A; Andueza Lillo, JA; Sanjurjo-Saez, M.

Level of concordance between two risk-assessment models for predicting venous thromboembolism in medical patients at admission

EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2016; 23(3): 141-144 [doi:10.1136/ejhpharm-2015-000694]

Ribed, A; Escudero-Vilaplana, V; Romero-Jimenez, RM; Iglesias-Peinado, I; Herranz-Alonso, A; Sanjurjo-Saez, M.

Guiding pharmacist clinical interviews: a safety tool to support the education of patients treated with oral antineoplastic agents

EXPERT OPINION ON DRUG SAFETY. 2016; 15(4): 427-435 Nº de citas: 15 [doi:10.1517/14740338.2016.1150998]

Ibanez-Garcia, S; Rodriguez-Gonzalez, CG; Martin-Barbero, ML; Sanjurjo-Saez, M; Herranz-Alonso, A.

Adding value through pharmacy validation: a safety and cost perspective

JOURNAL OF EVALUATION IN CLINICAL PRACTICE. 2016; 22(2): 253-260 Nº de citas: 11 [doi:10.1111/jep.12466]

Ribed, A; Romero-Jimenez, RM; Escudero-Vilaplana, V; Iglesias-Peinado, I; Herranz-Alonso, A; Codina, C; Sanjurjo-Saez, M.

Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction

International Journal of Clinical Pharmacy. 2016; 38(2): 280-288 Nº de citas: 65 [doi:10.1007/s11096-015-0235-8]

Garcia-Gonzalez X; Cabaleiro T; Herrero MJ; McLeod H; Lopez-Fernandez LA.

Clinical implementation of pharmacogenetics.

Drug Metabolism And Personalized Therapy. 2016; 31(1): 9-16 [doi:10.1515/dmpt-2015-0031]

Escudero-Vilaplana, V; Garcia-Gonzalez, X; Osorio-Prendes, S; Romero-Jimenez, RM; Sanjurjo-Saez, M.

Impact of medication adherence on the effectiveness of deferasirox for the treatment of transfusional iron overload in myelodysplastic syndrome

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2016; 41(1): 59-63 Nº de citas: 7 [doi:10.1111/jcpt.12348]

de Lorenzo-Pinto, A; Bueno, H; Cuellar-Basterrechea, B; Herranz-Alonso, A; Perez-Sanz, C; Rodriguez-Gonzalez, CG; Iglesias-Peinado, I; Fernandez-Aviles, F; Sanjurjo-Saez, M.

Optimisation of antithrombotic therapy in patients with acute coronary syndrome to reduce bleeding episodes

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 2016; 70(2): 156-162 Nº de citas: 2 [doi:10.1111/ijcp.12766]

Collado-Borrell R; Escudero-Vilaplana V; Ribed-Sánchez A; Ibáñez-García S; Herranz-Alonso A; Sanjurjo-Sáez M.

Smartphone applications for cancer patients; what we know about them?

FARMACIA HOSPITALARIA. 2016; 40(1): 25-35 Nº de citas: 57 [doi:10.7399/fh.2016.40.1.8993]

Marzal-Alfaro, MB; Manrique-Rodriguez, S; Yeste-Gomez, I; Pernia-Lopez, MS; Sanjurjo-Saez, M; Fernandez-Llamazares, CM.

Palatability Assessment of Oral Liquid Compounding Products in a Tertiary Pediatric Hospital

LATIN AMERICAN JOURNAL OF PHARMACY. 2016; 35: 1234-1240

Casado, LF; Burgos, A; Gonzalez-Haba, E; Loscertales, J; Krivasi, T; Orofino, J; Rubio-Terres, C; Rubio-Rodriguez, D.

Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain

ClinicoEconomics and Outcomes Research. 2016; 8: 475-484 Nº de citas: 9 [doi:10.2147/CEOR.S114524]

Gimenez-Manzorro, A; Garcia-Gonzalez, X; Rodriguez-Gonzalez, CG; Ochoa-Palominos, A; Sanjurjo-Saez, M; Clemente-Ricote, G.

Cost-effectiveness and safety of telaprevir and boceprevir for chronic hepatitis C in real-world clinical practice

Gastroenterologia y Hepatologia. 2015; 38(10): 575-582 Nº de citas: 4 [doi:10.1016/j.gastrohep.2015.07.002]

Buendía Bravo S; González Haba Peña E; García Sánchez R; Arrabal Durán P; Sánchez Fresneda MN; Sanjurjo Sáez M.

Análisis descriptivo de los motivos que originan visitas a urgencias en pacientes oncológicos: toxicidad postquimioterapia.

FARMACIA HOSPITALARIA. 2015; 39(6): 333-337 Nº de citas: 2 [doi:10.7399/fh.2015.39.6.8728]

Escudero-Vilaplana, V; Ramirez-Herraiz, E; Alanon-Plaza, E; Trovato-Lopez, N; Garcia-Vicuna, R; Carreno-Perez, L; Morell-Baladron, A; Sanjurjo-Saez, M.

Efficiency of adalimumab, etanercept and infliximab in ankylosing spondylitis in clinical practice

International Journal of Clinical Pharmacy. 2015; 37(5): 808-814 Nº de citas: 9 [doi:10.1007/s11096-015-0124-1]

Bodega, G; Segura, B; Ciordia, S; Mena, MD; Lopez-Fernandez, LA; Garcia, MI; Trabado, I; Suarez, I.

Ammonia Affects Astroglial Proliferation in Culture

PLoS One. 2015; 10(9): Nº de citas: 16 [doi:10.1371/journal.pone.0139619]